SLU-PP-332

Also known as: SLU PP 332, ERRα/γ agonist SLU-PP-332

Metabolic

Preclinical

SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors alpha and gamma (ERRα/ERRγ) — nuclear receptors that regulate mitochondrial biogenesis, oxidative metabolism, and energy expenditure. It mimics the metabolic effects of aerobic exercise at the cellular level, earning it the label of an 'exercise mimetic.' Studied for obesity, metabolic syndrome, heart failure, and muscular endurance.

Regulatory & Approval Status

Not FDA Approved

SLU-PP-332 is a research tool compound with no human clinical trials registered or conducted as of September 2026.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.